WILMINGTON – Prelude Therapeutics is one of Delaware’s burgeoning life science success stories, and it recently announced a new milestone in signing its first partnership agreement with a major Canadian […]
The portfolio companies of The Innovation Space recently eclipsed $1 billion in funding as the not-for-profit prepares for new tenants.
MRA Group, the developer behind the Chestnut Run Innovation and Science Park (CRISP), has secured $63 million in financing for the project.
Prelude Therapeutics announced Thursday that it’s selling millions of new shares to raise $100 million to support its drug pipeline research.
The first Delaware DNA conference hosted by the Delaware BioScience Association drew about 350 people to network and listen to panels.
Premier Digital Partners
© 2023 Delaware Business Times
